Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

465 ARTÍCULOS , VIENDO DEL 286 AL 300

Cerebrovascular reactivity to carbon dioxide in Alzheimer's disease

Glodzik L, Randall C, Rusinek H, de Leon MJ.

J Alzheimers Dis. 2013;35(3):427-40. doi: 10.3233/JAD-122011.

Psychiatry looks towards the future in neurodegenerative and neurodevelopmental disorders

Sachdev PS.

Curr Opin Psychiatry. 2013 May;26(3):237-8. doi: 10.1097/YCO.0b013e32835fd70e.

Neurodegenerative disease phenotypes in carriers of MAPT p.A152T, a risk factor for frontotemporal dementia spectrum disorders and Alzheimer disease

Lee SE, Tartaglia MC, Yener G, Genç S, Seeley WW, Sanchez-Juan P, Moreno F, Mendez MF, Klein E, Rademakers R, López de Munain A, Combarros O, Kramer JH, Kenet RO, Boxer AL, Geschwind MD, Gorno-Tempini ML, Karydas AM, Rabinovici GD, Coppola G, Geschwind DH, Miller BL.

Alzheimer Dis Assoc Disord. 2013 Oct-Dec;27(4):302-9. doi: 10.1097/WAD.0b013e31828cc357.

Benzodiazepine and dementia: a time for reflection

Bocti C, Roy-Desruisseaux J, Hudon C, Roberge P.

Maturitas. 2013 Jun;75(2):105-6. doi: 10.1016/j.maturitas.2013.03.001. Epub 2013 Mar 26.

Risk factors for β-amyloid deposition in healthy aging: vascular and genetic effects

Rodrigue KM, Rieck JR, Kennedy KM, Devous MD Sr, Diaz-Arrastia R, Park DC.

JAMA Neurol. 2013 May;70(5):600-6. doi: 10.1001/jamaneurol.2013.1342.

Genetic testing for early-onset Alzheimer disease

Tsao JW.

Continuum (Minneap Minn). 2013 Apr;19(2 Dementia):475-9. doi: 10.1212/01.CON.0000429170.50686.4e.

Sundowning syndrome: a possible marker of frailty in Alzheimer's disease?

Ferrazzoli D, Sica F, Sancesario G.

CNS Neurol Disord Drug Targets. 2013 Jun;12(4):525-8. doi: 10.2174/18715273113129990065.

MR imaging features of amyloid-related imaging abnormalities

Barakos J, Sperling R, Salloway S, Jack C, Gass A, Fiebach JB, Tampieri D, Melançon D, Miaux Y, Rippon G, Black R, Lu Y, Brashear HR, Arrighi HM, Morris KA, Grundman M.

AJNR Am J Neuroradiol. 2013 Oct;34(10):1958-65. doi: 10.3174/ajnr.A3500. Epub 2013 Apr 11.

Non-Gaussian diffusion MRI assessment of brain microstructure in mild cognitive impairment and Alzheimer's disease

Falangola MF, Jensen JH, Tabesh A, Hu C, Deardorff RL, Babb JS, Ferris S, Helpern JA.

Magn Reson Imaging. 2013 Jul;31(6):840-6. doi: 10.1016/j.mri.2013.02.008. Epub 2013 Apr 18.

Progranulin mutations as risk factors for Alzheimer disease

Perry DC, Lehmann M, Yokoyama JS, Karydas A, Lee JJ, Coppola G, Grinberg LT, Geschwind D, Seeley WW, Miller BL, Rosen H, Rabinovici G.

JAMA Neurol. 2013 Jun;70(6):774-8. doi: 10.1001/2013.jamaneurol.393.

Alzheimer's disease risk, obesity and tau: is insulin resistance guilty?

Blum D, Buée L.

Expert Rev Neurother. 2013 May;13(5):461-3. doi: 10.1586/ern.13.35.

White matter abnormalities associated with Alzheimer's disease and mild cognitive impairment: a critical review of MRI studies

Radanovic M, Pereira FR, Stella F, Aprahamian I, Ferreira LK, Forlenza OV, Busatto GF.

Expert Rev Neurother. 2013 May;13(5):483-93. doi: 10.1586/ern.13.45.

Vascular risk factors and neurodegeneration in ageing related dementias: Alzheimer's disease and vascular dementia

Akinyemi RO, Mukaetova-Ladinska EB, Attems J, Ihara M, Kalaria RN.

Curr Alzheimer Res. 2013 Jul;10(6):642-53. doi: 10.2174/15672050113109990037.

Decreased functional connectivity of the amygdala in Alzheimer's disease revealed by resting-state fMRI

Yao H, Liu Y, Zhou B, Zhang Z, An N, Wang P, Wang L, Zhang X, Jiang T.

Eur J Radiol. 2013 Sep;82(9):1531-8. doi: 10.1016/j.ejrad.2013.03.019. Epub 2013 May 3.

Optimal blood pressure for cognitive function: findings from an elderly African-American cohort study

Liu H, Gao S, Hall KS, Unverzagt FW, Lane KA, Callahan CM, Hendrie HC.

J Am Geriatr Soc. 2013 Jun;61(6):875-881. doi: 10.1111/jgs.12259. Epub 2013 May 6.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias